Bildnachweis: Fotolia
    Logo News Medizin 2000
      >    Zurück

  | Suche | Nutzung | Impressum | Kontakt | 22.05.17, Uhrzeit: 23.24

Themen Websites A-Z im Info-Netzwerk
MEDIZIN 2000
 

 

 

Soziale Netzwerke


    



Aktuelle Informationen und News

rund um die Themenkomplexe
Medizin, Gesundheit und Wohlfühlen
 

  2012  

 

Fehldiagnosen
Bluthochdruck und Herz-Kreislauferkrankungen
Die Diagnose Bluthochdruck ist häufig eine Fehldiagnose und zieht bei vielen zehntausend Patienten überflüssige, nebenwirkungsbelastete  und teure  Arzneimitteltherapien nach sich.

Jüngste Forschungsergebnisse zeigten, dass die mit schweren  Nebenwirkungen behaftete medikamentöse Therapie bei leichtem bis mittelgradigem Bluthochdruck das Herz-Kreislauf-Risiko nicht positiv beeinflusst und daher überflüssig ist (siehe hier). 
Hinzu kommt, dass die Diagnose Bluthochdruck häufig ausschließlich aufgrund von wenigen Messungen gestellt wird, die ausschließlich in der Arztpraxis durchgeführt wurden. Doch dort wird insbesondere bei sensiblen Menschen lediglich ein sog. "Weißkittel-Bluthochdruck" festgestellt - ein Blutdruck also, der aufgrund von psychischem Stress kurzfristig erhöht war und keinerlei negative Folgen hat.
Dieser kurzfristig erhöhte Blutdruck kann dann bei Messungen im normalen Umfeld des jeweiligen Patienten - meist durch diesen selbst durchgeführt - nicht bestätigt werden.
Bereits im Jahr 2011 konnten spanische Wissenschaftler zeigen, dass diese verhängnisvollen Fehldiagnosen alles andere als selten sind. Eine Arbeitsgruppe um Professor de la Sierra, Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona, wies nach, dass unter mehr als 68.000 Hochdruckpatienten 8.295 unter einer therapieresistenten Hypertonie litten. Von diesen hatten wiederum 37,5% lediglich eine "Weißkittel-Hypertonie" hatten und somit keine blutdrucksenkende Behandlung benötigten. Die Therapieresistenz wurde dokumentiert, wenn der in der Arztpraxis gemessene Blutdruck - trotz der Gabe von mindestens drei blutdrucksenkenden Medikamenten - nicht unter über 140/90 mm Hg abgesenkt werden konnte. 
Wie hoch der Anteil der Weißkittel-Pseudo-Hypertonien bei den rund 60.000 Hypertonikern war, die auf die verabreichten Medikamente mit der gewünschten Blutdrucksenkung reagierten, blieb in der Studie ungeklärt.

Alejandro de la Sierra, M.D., ad author of the study and director of internal medicine at Hospital Mutua Terrassa, University of Barcelona in Spain. "W

Read more at: http://phys.org/news/2011-03-ambulatory-reveals-patients-white-coat.html#jCp
Ambulatory monitoring reveals many patients have 'white coat' hypertension March 28, 2011 A third of patients thought to have resistant hypertension had "white coat" hypertension during 24-hour ambulatory monitoring, in a large study reported in Hypertension: Journal of the American Heart Association. Ads by Google Brain Training Games - Improve memory and attention with scientific brain games. - www.lumosity.com In ambulatory blood pressure monitoring, the patient's blood pressure is checked at regular intervals under normal living and working conditions. Resistant hypertension occurs when a patient's blood pressure remains above treatment goals, despite using three different types of drugs at the same time. In "white coat" hypertension, a patient's blood pressure is high at the doctor's office but normal in everyday life. "Ambulatory monitoring showed that many of these patients' blood pressures were in the normal range when they were at home or participating in their usual activities," said Alejandro de la Sierra, M.D., lead author of the study and director of internal medicine at Hospital Mutua Terrassa, University of Barcelona in Spain. "While those who actually had 'white coat' hypertension are not risk free, their cardiovascular outcomes are much better." The study included 69,045 patients with hypertension — defined as systolic blood pressure of 140 millimeters of mercury (mm Hg) or above and diastolic blood pressure of 90 mm Hg or above — in the Spanish Ambulatory Blood Pressure registry. Fifty-one percent were men and their average age was 64 years. Thirty-seven percent of 8,295 patients determined to have resistant hypertension had "white coat" hypertension after being tested with ambulatory blood pressure monitoring for 24 hours. Close to 63 percent had true resistant hypertension. Researchers based blood pressure estimates on two readings. They took ambulatory blood pressure every 20 minutes during the day and night and assessed age, gender, weight, height, body mass index, duration of hypertension and known cardiovascular risk factors such as smoking, diabetes, lipid profile, creatinine levels, electrocardiograms and clinical cardiovascular disease. The researchers found: More women (42 percent) had "white coat" hypertension with ambulatory blood pressure monitoring than men (34 percent). Those with true resistant hypertension appeared slightly younger, were more likely male, had a longer duration of hypertension and a worse cardiovascular risk profile. Those with true resistant hypertension included a higher number of smokers, diabetics, and patients with left ventricular hypertrophy and previous cardiovascular disease. "Those with true resistant hypertension showed high blood pressure at work, during the day and at night," de la Sierra said. "The true resistant group also was more likely to have blood pressures that abnormally rose during the night when they were sleeping." It made no difference in target blood pressure goals if antihypertensive medications were given either in the morning or at night, researchers said. "Ambulatory blood pressure monitoring should be mandatory in resistant hypertension patients to define true and 'white coat' hypertension," de la Sierra said. Limitations of the study included its cross-sectional nature and the lack of information to determine whether patients were taking medications correctly. However, the high number of patients more closely matched the usual clinical practice treated by primary care physicians and referral centers. "Physicians should be encouraged to use ambulatory monitoring to confirm resistant hypertension in their patients as it would ensure the most effect treatment options are used," de la Sierra said. "Patients benefit by knowing whether their blood pressure is normal during daily activities or still needs the reinforcement of dietary and drug measures to achieve the goal." Provided by American Heart Association search and more info website

Read more at: http://phys.org/news/2011-03-ambulatory-reveals-patients-white-coat.html#jCp
Ambulatory monitoring reveals many patients have 'white coat' hypertension March 28, 2011 A third of patients thought to have resistant hypertension had "white coat" hypertension during 24-hour ambulatory monitoring, in a large study reported in Hypertension: Journal of the American Heart Association. Ads by Google Brain Training Games - Improve memory and attention with scientific brain games. - www.lumosity.com In ambulatory blood pressure monitoring, the patient's blood pressure is checked at regular intervals under normal living and working conditions. Resistant hypertension occurs when a patient's blood pressure remains above treatment goals, despite using three different types of drugs at the same time. In "white coat" hypertension, a patient's blood pressure is high at the doctor's office but normal in everyday life. "Ambulatory monitoring showed that many of these patients' blood pressures were in the normal range when they were at home or participating in their usual activities," said Alejandro de la Sierra, M.D., lead author of the study and director of internal medicine at Hospital Mutua Terrassa, University of Barcelona in Spain. "While those who actually had 'white coat' hypertension are not risk free, their cardiovascular outcomes are much better." The study included 69,045 patients with hypertension — defined as systolic blood pressure of 140 millimeters of mercury (mm Hg) or above and diastolic blood pressure of 90 mm Hg or above — in the Spanish Ambulatory Blood Pressure registry. Fifty-one percent were men and their average age was 64 years. Thirty-seven percent of 8,295 patients determined to have resistant hypertension had "white coat" hypertension after being tested with ambulatory blood pressure monitoring for 24 hours. Close to 63 percent had true resistant hypertension. Researchers based blood pressure estimates on two readings. They took ambulatory blood pressure every 20 minutes during the day and night and assessed age, gender, weight, height, body mass index, duration of hypertension and known cardiovascular risk factors such as smoking, diabetes, lipid profile, creatinine levels, electrocardiograms and clinical cardiovascular disease. The researchers found: More women (42 percent) had "white coat" hypertension with ambulatory blood pressure monitoring than men (34 percent). Those with true resistant hypertension appeared slightly younger, were more likely male, had a longer duration of hypertension and a worse cardiovascular risk profile. Those with true resistant hypertension included a higher number of smokers, diabetics, and patients with left ventricular hypertrophy and previous cardiovascular disease. "Those with true resistant hypertension showed high blood pressure at work, during the day and at night," de la Sierra said. "The true resistant group also was more likely to have blood pressures that abnormally rose during the night when they were sleeping." It made no difference in target blood pressure goals if antihypertensive medications were given either in the morning or at night, researchers said. "Ambulatory blood pressure monitoring should be mandatory in resistant hypertension patients to define true and 'white coat' hypertension," de la Sierra said. Limitations of the study included its cross-sectional nature and the lack of information to determine whether patients were taking medications correctly. However, the high number of patients more closely matched the usual clinical practice treated by primary care physicians and referral centers. "Physicians should be encouraged to use ambulatory monitoring to confirm resistant hypertension in their patients as it would ensure the most effect treatment options are used," de la Sierra said. "Patients benefit by knowing whether their blood pressure is normal during daily activities or still needs the reinforcement of dietary and drug measures to achieve the goal." Provided by American Heart Association search and more info website

Read more at: http://phys.org/news/2011-03-ambulatory-reveals-patients-white-coat.html#jCp
Ambulatory monitoring reveals many patients have 'white coat' hypertension March 28, 2011 A third of patients thought to have resistant hypertension had "white coat" hypertension during 24-hour ambulatory monitoring, in a large study reported in Hypertension: Journal of the American Heart Association. Ads by Google Brain Training Games - Improve memory and attention with scientific brain games. - www.lumosity.com In ambulatory blood pressure monitoring, the patient's blood pressure is checked at regular intervals under normal living and working conditions. Resistant hypertension occurs when a patient's blood pressure remains above treatment goals, despite using three different types of drugs at the same time. In "white coat" hypertension, a patient's blood pressure is high at the doctor's office but normal in everyday life. "Ambulatory monitoring showed that many of these patients' blood pressures were in the normal range when they were at home or participating in their usual activities," said Alejandro de la Sierra, M.D., lead author of the study and director of internal medicine at Hospital Mutua Terrassa, University of Barcelona in Spain. "While those who actually had 'white coat' hypertension are not risk free, their cardiovascular outcomes are much better." The study included 69,045 patients with hypertension — defined as systolic blood pressure of 140 millimeters of mercury (mm Hg) or above and diastolic blood pressure of 90 mm Hg or above — in the Spanish Ambulatory Blood Pressure registry. Fifty-one percent were men and their average age was 64 years. Thirty-seven percent of 8,295 patients determined to have resistant hypertension had "white coat" hypertension after being tested with ambulatory blood pressure monitoring for 24 hours. Close to 63 percent had true resistant hypertension. Researchers based blood pressure estimates on two readings. They took ambulatory blood pressure every 20 minutes during the day and night and assessed age, gender, weight, height, body mass index, duration of hypertension and known cardiovascular risk factors such as smoking, diabetes, lipid profile, creatinine levels, electrocardiograms and clinical cardiovascular disease. The researchers found: More women (42 percent) had "white coat" hypertension with ambulatory blood pressure monitoring than men (34 percent). Those with true resistant hypertension appeared slightly younger, were more likely male, had a longer duration of hypertension and a worse cardiovascular risk profile. Those with true resistant hypertension included a higher number of smokers, diabetics, and patients with left ventricular hypertrophy and previous cardiovascular disease. "Those with true resistant hypertension showed high blood pressure at work, during the day and at night," de la Sierra said. "The true resistant group also was more likely to have blood pressures that abnormally rose during the night when they were sleeping." It made no difference in target blood pressure goals if antihypertensive medications were given either in the morning or at night, researchers said. "Ambulatory blood pressure monitoring should be mandatory in resistant hypertension patients to define true and 'white coat' hypertension," de la Sierra said. Limitations of the study included its cross-sectional nature and the lack of information to determine whether patients were taking medications correctly. However, the high number of patients more closely matched the usual clinical practice treated by primary care physicians and referral centers. "Physicians should be encouraged to use ambulatory monitoring to confirm resistant hypertension in their patients as it would ensure the most effect treatment options are used," de la Sierra said. "Patients benefit by knowing whether their blood pressure is normal during daily activities or still needs the reinforcement of dietary and drug measures to achieve the goal." Provided by American Heart Association search and more info website

Read more at: http://phys.org/news/2011-03-ambulatory-reveals-patients-white-coat.html#jCp

 Quelle: Hypertension, Journal of the American Heart Association 2011

Zur Originalquelle hier (kostenloser Volltext in englischer Sprache)

  

 

Der nachfolgend dargestellte Text wurde in der werbefreien online Enzyklopädie WIKIPEDIA  der Lizenz „Creative Commons Attribution/Share Alike“ für die freie Weiterverbreitung publiziert. Nähere Angaben zu dieser Lizenz finden Sie hier. Sollte Ihr Browser keine Frames darstellen, so können Sie den zum Thema Bluthochdruck publizierten Text auch hier abrufen.  Angaben zu früheren Versionen dieses Textes und zu den Autoren des Beitrags finden Sie hier.

 

 

 

 

 

 




 
[an error occurred while processing this directive]


 
  Mittelteil News werbefrei
WERBUNG INFO-NETZWERK MEDIZIN 2000












 
 
 













 



 
 





 



 





 





 







 

 
 



 

 

 

>    zum Seitenanfang 

zurück zum Index

 

 

 




 
 

Twitter auf Medizin 2000

 
            Werbung

Sie möchten die werbenden Texte in Ruhe durchlesen?
Kein Problem: die Bilderabfolge kann mit der Maus beliebig lange angehalten werden.

 

                           

 

 

Linkliste Medizin 2000

Wichtige Themen-Websites im Info-Netzwerk Medizin 2000      aktualisiert 8.2.22017
 
 | Anthroposophie | Adipositas Therapie | AIDS/HIV | Alkohol | Allergie Therapie | allergisches Asthma | Angstpatienten | Ärzte |   alternative Krebs Therapie | Antibabypille |
| Atemgas-Analyse  | Apotheken | Arterienverkalkung | Arzt Beruf |  Ärzte | Arhrose Rheuma Therapie | Aspirin-Therapie | Asthma | Asthma Therapie | Asthma Management |
| Asthma Diagnose | Audio Podcast Augenheilkunde | Basalinsulin | Bienengift Allergie | Biologischer Bypass | Brustkrebs Behandlung COPD Therapie | Deutsche Ärzte |
|  Deutsche Fachärzte | Diabetes / Zuckerkrankheit | Depressionen | Diagnostica aktuell | Durchblutung | Erektile Dysfunktion |   Endoprothese | Erkältungen | FeNO-Atemtest |

| Herzinfarkt Therapie Herzinsuffizienz Therapie | Herzinsuffizienz Diagnose Herzschrittmacher | Herzkrankheiten Heuschnupfen Therapie | Highlights Forschung | Hochzeit |
 | Homöopathie | Homöopunktur | Hörgeräte | Hüftgelenk Endoprothese Hundehaar Allergie | Hunde Vermittlung | Hundshuus | Hyperthermie | Hyperthermie Therapie   |
Humangenetik | Hypertonie Therapie   | Impotenz Therapie | IDS | Impf - Schutz | Insektengift Allergie | inhalierbares Insulin  | Integrative Medizin |  Internet-Apotheken |
| Kardiologie aktuell   |  Katzenhaar Allergie | Kniegelenks Endoprothese | Komplementärmedizin Onkologie | Kontaktlinsen | Krankenhäuser | Krebstherapie News |
| Krebserkrankungen   | Latex Allergie | LHMS | Lebensmittel Allergie | Magenleiden  | Medikamente News | Medizintechnik Medizin Recht |
Micronjet-Technologie Molekulare-Allergiediagnostik   | Minimal invasive Operationstechniken  | Mistel Therapie Krebs  | Nagelpilz | Naturheilverfahren |
  | Naturheilkunde | Natürlich heilen | Nervenkrankheiten | Nierenkrebs Therapie | Notfall Medizin | Onkologie News | online Hausarzt | Orthomolekulare Medizin |
   | Orthopädie Osteoporose | Pilates-Methode | Pilzerkrankungen | Pollenallergie News | Presseerklärungen Medizin | Presseerklärungen Pharmaindustrie | Presseerklärungen Gesundheitspolitik |
| Presseerklärungen Pharmaunternehmen | Presseerklärungen Krankenhäuser | Presseerklärungen Krankenkassen | Ragweedallergie | Reha | Reisemedizin |   rheumatische Arthritis |
   | Report Medizin | Rheuma | Science Podcast   | Scheidenpilz | Schmerztherapie | Schwerhörigkeit | Selbstheilung | Selbsthilfe Gruppen |   Spezifische Immuntherapie SIT |
 | Spires Allergietherapie | Sport Medizin | Stammzellforschung | Sublinguale spezifische Immuntherapie SLIT | Thymus Therapie | Tierhaarallergie | Tierschutz Toleromune Technolgie |
| Totalendoprothese TEP | unspezifische Immuntherapie |   Vaterschaftstest Video Podcast   | Virusgrippe | Vital-Test | Vitamine und Spurenelemente | Wespengift Allergie |
| ZNS Erkrankungen | Zuckerkrankheit | Info- Netzwerk Medizin 2000 | Nutzungsbedingungen | Stichwortsuche Medizin 2000 | Impressum |
| Graspollen Allergie2 | Hausstaubmilben Allergie2| Katzenhaar Allergie 2|  Ragweed Allergie 2|  Heiraten |